Your Health, We Care

Home >Drug List>Infigratinib>Indications of Infigratinib

Infigratinib(Truseltiq)

Release date: 2026-01-05 14:23:40     Recommended: 53

It is indicated for the treatment of adult patients with previously treated, unresectable locally advanced or metastatic cholangiocarcinoma with FGFR2 gene abnormalities.